112921-11-6
112921-11-6
Chemical Structure
GlyRS-IN-1
- CAS No.: 112921-11-6
- Formula:C12H17N7O7S
- Molecular Weight:403.37
IUPAC Name: ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl glycylsulfamate
InChIKey: AMWPZASLDLLQFT-JJNLEZRASA-N
SMILES: NC1=C2N=CN([C@@H]([C@H](O)[C@@H]3O)O[C@@H]3COS(=O)(NC(CN)=O)=O)C2=NC=N1
Biological Activity: GlyRS-IN-1 is a GlyRS inhibitor. GlyRS-IN-1 reduces lung metastasis in breast cancer mice. GlyRS-IN-1 can be used in research on breast cancer, non-small cell lung cancer, renal cancer, prostate cancer, ovarian cancer, leukemia, and colon cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GlyRS-IN-1 | 99.40% | GlyRS-IN-1 is a GlyRS inhibitor. GlyRS-IN-1 reduces lung metastasis in breast cancer mice. GlyRS-IN-1 can be used in research on breast cancer, non-small cell lung cancer, renal cancer, prostate cancer, ovarian cancer, leukemia, and colon cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GlyRS-IN-1 (Standard) | ≥98% | GlyRS-IN-1 (Standard) is the analytical standard of GlyRS-IN-1 (HY-108940). This product is intended for research and analytical applications. GlyRS-IN-1 is a GlyRS inhibitor. GlyRS-IN-1 reduces lung metastasis in breast cancer mice. GlyRS-IN-1 can be used in research on breast cancer, non-small cell lung cancer, renal cancer, prostate cancer, ovarian cancer, leukemia, and colon cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
